Literature DB >> 6997425

Macrophages elicited with heat-killed bacillus Calomette-Guérin protect C57BL/6J mice against a syngeneic melanoma.

V H Freedman, T A Calvelli, S Silagi, S C Silverstein.   

Abstract

We have demonstrated that a murine cytotoxic peritoneal cell can be elicited by intraperitoneal immunization with heat-killed Mycobacterium bovis, strain Bacillus Calmette-Guérin (BCG). When these cells are injected together with cells of clone B(5)59 of B16 melanoma in a Winn-type transfer assay into syngeneic C57BL/6J mice, the tumorigenic potential of the melanoma is completely abrogated. Similarly, mice immunized intraperitoneally with dead BCG are protected against intraperitoneal challenge with a number of B16 melanoma cells sufficient to cause tumors in 100% of control mice. However, mice immunized intraperitoneally with dead BCG are not protected against tumor formation when B16 melanoma cells are injected subcutaneously. Co-injection of BCG-elicited peritoneal cells with B16 melanoma cells into nude or sublethally irradiated (650 rad) mice inhibits tumor formation in > 85% of the mice, indicating that additional participation of host bone marrow- or thymus-derived leukocytes is not required to eradicate the tumor implant. The effector cell in the BCG-induced peritoneal exudate is adherent and phagocytic and is a mononuclear phagocyte. Nonadherent lymphoid cells from the same BCG-induced peritoneal exudate and from thioglycollate-broth-elicited granylocytes and macrophages neither prevent nor delay B16 tumor formation.

Entities:  

Mesh:

Year:  1980        PMID: 6997425      PMCID: PMC2185920          DOI: 10.1084/jem.152.3.657

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  37 in total

1.  Histopathology of tumor regression after intralesional injection of Mycobacterium bovis., 2. Comparative effects of vaccinia virus, oxazolone, and turpentine.

Authors:  M G Hanna; B Zbar; H J Rapp
Journal:  J Natl Cancer Inst       Date:  1972-06       Impact factor: 13.506

2.  Histopathology of tumor regression after intralesional injection of Mycobacterium bovis. I. Tumor growth and metastasis.

Authors:  M G Hanna; B Zbar; H J Rapp
Journal:  J Natl Cancer Inst       Date:  1972-05       Impact factor: 13.506

3.  Tumor cytotoxicity in vitro by macrophages from mice infected with mycobacterium bovis strain BCG.

Authors:  R P Cleveland; M S Meltzer; B Zbar
Journal:  J Natl Cancer Inst       Date:  1974-06       Impact factor: 13.506

4.  A human mononuclear leukocyte chemotactic factor: characterization, specificity and kinetics of production by homologous leukocytes.

Authors:  L C Altman; R Snyderman; J J Oppenheim; S E Mergenhagen
Journal:  J Immunol       Date:  1973-03       Impact factor: 5.422

5.  In vitro nonimmunologic destruction of cells with abnormal growth characteristics by adjuvant activated macrophages.

Authors:  J B Hibbs; L H Lambert; J S Remington
Journal:  Proc Soc Exp Biol Med       Date:  1972-03

6.  Modification of malignancy by 5-bromodeoxyuridine. Studies of reversibility and immunological effects.

Authors:  S Silagi
Journal:  In Vitro       Date:  1971 Sep-Oct

7.  Suppression of malignancy and differentiation in melanotic melanoma cells.

Authors:  S Silagi; S A Bruce
Journal:  Proc Natl Acad Sci U S A       Date:  1970-05       Impact factor: 11.205

8.  Cellular kinetics associated with the development of acquired cellular resistance.

Authors:  R J North
Journal:  J Exp Med       Date:  1969-08-01       Impact factor: 14.307

9.  The interaction of particulate horseradish peroxidase (HRP)-anti HRP immune complexes with mouse peritoneal macrophages in vitro.

Authors:  R M Steinman; Z A Cohn
Journal:  J Cell Biol       Date:  1972-12       Impact factor: 10.539

10.  Control of pigment production in mouse melanoma cells in vitro. Evocation and maintenance.

Authors:  S Silagi
Journal:  J Cell Biol       Date:  1969-11       Impact factor: 10.539

View more
  10 in total

1.  Enhancement of hematopoietic response of mice by subcutaneous administration of Lactobacillus casei.

Authors:  T Yokokura; K Nomoto; T Shimizu; K Nomoto
Journal:  Infect Immun       Date:  1986-04       Impact factor: 3.441

2.  Infection of DBA/2 or C3H/HeJ mice by intraperitoneal injection of vaccinia virus elicits activated macrophages, cytolytic and cytostatic for S91-melanoma tumor cells.

Authors:  R J Natuk; J A Byrne; J A Holowczak
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

3.  Anti-tumour effect of humoral and cellular immunities mediated by a bacterial immunopotentiator, Lactobacillus casei, in mice.

Authors:  N Yasutake; M Ohwaki; M Mutai; Y Koide; T Yoshida
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

4.  Role of macrophages in serum colony-stimulating factor induction by Lactobacillus casei in mice.

Authors:  M Nanno; T Shimizu; A Mike; M Ohwaki; M Mutai
Journal:  Infect Immun       Date:  1988-02       Impact factor: 3.441

5.  Activation of mouse peritoneal macrophages by monoclonal antibodies to Mac-1 (complement receptor type 3).

Authors:  A Ding; S D Wright; C Nathan
Journal:  J Exp Med       Date:  1987-03-01       Impact factor: 14.307

6.  Leukocyte subpopulations elicited by a nontumorigenic variant of B16 melanoma: their role in direct rejection of the melanoma and in prevention of tumorigenesis in Winn assays.

Authors:  T A Calvelli; V H Freedman; S C Silverstein; S Silagi
Journal:  J Exp Med       Date:  1982-12-01       Impact factor: 14.307

7.  Surface properties of bacillus Calmette-Guérin-activated mouse macrophages. Reduced expression of mannose-specific endocytosis, Fc receptors, and antigen F4/80 accompanies induction of Ia.

Authors:  R A Ezekowitz; J Austyn; P D Stahl; S Gordon
Journal:  J Exp Med       Date:  1981-07-01       Impact factor: 14.307

8.  Binding of bacillus Calmette-Guérin-activated macrophages to tumor targets. Selective inhibition by membrane preparations from homologous and heterologous neoplastic cells.

Authors:  P A Marino; C C Whisnant; D O Adams
Journal:  J Exp Med       Date:  1981-07-01       Impact factor: 14.307

9.  Down-regulation of mannosyl receptor-mediated endocytosis and antigen F4/80 in bacillus Calmette-Guérin-activated mouse macrophages. Role of T lymphocytes and lymphokines.

Authors:  R A Ezekowitz; S Gordon
Journal:  J Exp Med       Date:  1982-06-01       Impact factor: 14.307

10.  Bacillus Calmette-Guérin-activated murine macrophages kill syngeneic melanoma cells under strict anaerobic conditions.

Authors:  V H Freedman; T E Gorrell; C F Nathan; C S Copeland; S C Silverstein
Journal:  J Exp Med       Date:  1984-07-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.